CorMedix (CRMD) Gross Profit (2016 - 2025)
CorMedix has reported Gross Profit over the past 12 years, most recently at $107.3 million for Q4 2025.
- Quarterly results put Gross Profit at $107.3 million for Q4 2025, up 257.28% from a year ago — trailing twelve months through Dec 2025 was $275.7 million (up 584.54% YoY), and the annual figure for FY2025 was $275.7 million, up 584.54%.
- Gross Profit reached $107.3 million in Q4 2025 per CRMD's latest filing, up from $93.1 million in the prior quarter.
- Across five years, Gross Profit topped out at $107.3 million in Q4 2025 and bottomed at -$818539.0 in Q1 2024.
- Median Gross Profit over the past 4 years was $28109.0 (2021), compared with a mean of $19.8 million.
- The largest annual shift saw Gross Profit crashed 127.47% in 2021 before it soared 12683.29% in 2025.
- Over 4 years, Gross Profit stood at $8390.0 in 2021, then surged by 249.18% to $29296.0 in 2022, then soared by 102421.64% to $30.0 million in 2024, then surged by 257.28% to $107.3 million in 2025.
- Business Quant data shows Gross Profit for CRMD at $107.3 million in Q4 2025, $93.1 million in Q3 2025, and $37.9 million in Q2 2025.